Pharmaceutically acceptable salts of 2-chloro-N-(4-chloro-3- (pyridin-2-yl)-phenyl)-4-(methylsulfonyl)benzamide

Pharmaceutically acceptable salts of 2-chloro-N-(4-chloro-3- (pyridin-2-yl)-phenyl)-4-(methylsulfonyl)benzamide

The technical solution describes a salt of a compound of formula (I) with the acid component selected from the group consisting of hydrobromic acid, benzenesulfonic acid, 4-chlorobenzenesulphonic acid and p-toluenesulfonic acid. Technické riešenie opisuje soľ zlúčeniny vzorca (I) s kyslou zložkou zv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DAMMER ONDREJ, TOZICKOVA HANA, KISS VIOLETTA, TKADLECOVA MARCELA, RIDVAN LUDEK, KREJCIK LUKAS
Format: Patent
Sprache:eng ; slo
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The technical solution describes a salt of a compound of formula (I) with the acid component selected from the group consisting of hydrobromic acid, benzenesulfonic acid, 4-chlorobenzenesulphonic acid and p-toluenesulfonic acid. Technické riešenie opisuje soľ zlúčeniny vzorca (I) s kyslou zložkou zvolenou zo skupiny obsahujúcej kyselinu bromovodíkovú, kyselinu benzénsulfónovú, kyselinu 4-chlórbenzénsulfónovú a kyselinu p-toluénsulfónovú.